GlassScriptPhysician profile
Brian T Abbey
NPI 1407960917
$6,412.83
in general payments reported to CMS, 2019-2025
30 companies · $4,330 in 2025
The $4,330 reported for 2025 was more than what 95% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $284 · 2020: $308 · 2021: $216 · 2022: $156 · 2023: $594 · 2024: $525 · 2025: $4,330.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $4,000 · Food and Beverage: $1,450.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $4,000.00 |
| Food and Beverage | $1,449.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $4,039.12 | 2020-2025 | |
| Smith+Nephew, INC. | $468.26 | 2019-2025 | Regranex, Collagenase Santyl, Grafix Pl |
| Paratek Pharmaceuticals, INC. | $415.62 | 2021-2025 | Nuzyra |
| Integra Lifesciences Corporation | $312.61 | 2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Medtronic, INC. | $195.10 | 2021-2024 | Closurefast |
| Acera Surgical, INC. | $126.85 | 2020 | |
| Treace Medical Concepts, INC. | $109.25 | 2022-2025 | |
| Melinta Therapeutics, LLC | $97.39 | 2019-2021 | |
| Next Science LLC | $72.76 | 2025 | Blastx, Xperience |
| Globus Medical, INC. | $70.19 | 2025 | Senza |
| Bioventus LLC | $65.43 | 2021-2022 | |
| Kci USA, INC. | $52.39 | 2019 | |
| Amniox Medical, INC. | $35.63 | 2020 | |
| Hikma Pharmaceuticals USA | $32.80 | 2019-2020 | |
| Reddress USA, INC. | $31.81 | 2024 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ets Wound Care LLC | $27.94 | 2024 | Mirragen Advanced Wound Matrix |
| Abbvie INC. | $26.51 | 2025 | |
| Tactile Systems Technology INC | $24.91 | 2019 | |
| Ibsa Pharma INC. | $23.71 | 2023 | Tirosint, Licart |
| Hartmann USA, INC. | $20.05 | 2025 | Zetuvit Plus 10x10 P10 |
| Imbed Biosciences INC. | $20.00 | 2022 | |
| Nevro Corp. | $19.84 | 2023 | Senza |
| Fidia Pharma USA INC. | $19.19 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $17.52 | 2023 | Seglentis |
| Becton, Dickinson and Company | $16.35 | 2019 | |
| Zyla Life Sciences, INC. | $16.27 | 2019 | |
| Polynovo North America LLC | $15.58 | 2025 | Novosorb Btm |
| Cashflow Solutions, LLC | $13.84 | 2022 | |
| Acell, INC. | $13.44 | 2019 | |
| Allergan, INC. | $12.47 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Abbey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.